The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Thomas Powles
Honoraria - Astellas Pharma; AstraZeneca; BMS GmbH & Co. KG; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson/Janssen; MashupMD; Merck; Merck Serono; Novartis; Pfizer; Roche; Seagen
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Incyte; Ipsen; Johnson & Johnson; MashupMD; Merck; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Research Funding - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Eisai; Exelixis; Ipsen; Johnson & Johnson; Merck Serono; MSD; Novartis; Pfizer; Roche; Seagen
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; MSD; Pfizer; Roche
 
Jessia Grindheim
Employment - Genentech/Roche
Research Funding - Genentech/Roche
 
Mesut Yilmaz
Research Funding - Genentech/Roche (Inst)
 
Grigorios Rallis
Research Funding - Genentech/Roche (Inst)
 
Mahmut Gumus
Honoraria - Bayer (Inst); Daiichi Sankyo/Astra Zeneca (Inst); GlaxoSmithKline (Inst); MSD Oncology (Inst); Novartis (Inst); Pfizer (Inst)
Consulting or Advisory Role - Amgen (Inst); Astellas Pharma (Inst); Gen (Inst); Gilead Sciences (Inst); Lilly (Inst); Novartis (Inst); Roche; Takeda (Inst)
Speakers' Bureau - Amgen (Inst); MSD Oncology (Inst); Novartis (Inst); Polipharma (Inst); Roche (Inst)
Research Funding - Amgen (Inst); AstraZeneca (Inst); Gilead Sciences (Inst); MSD Oncology (Inst); Pfizer (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Consuelo Buttigliero
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen-Cilag; Merck
Speakers' Bureau - ipsen
Research Funding - Genentech/Roche (Inst)
 
Teresa Bonfill
Research Funding - Genentech/Roche (Inst)
 
Franco Nole
No Relationships to Disclose
 
Ho Kyung Seo
Speakers' Bureau - Astellas Pharma; Janssen; Merck; Ono Pharmaceutical
Research Funding - Abbvie; Astellas Pharma; AstraZeneca; Gilead Sciences; Janssen Oncology; Merck; MSD Oncology; Ono Pharmaceutical; Pfizer; Roche; Seagen
 
Michaela Matouskova
Research Funding - Genentech/Roche (Inst)
 
Iwona Skoneczna
Research Funding - Genentech/Roche (Inst)
 
Wim Demey
Research Funding - Genentech/Roche (Inst)
 
Patrizia Giannatempo
Honoraria - Astellas Pharma; Gilead Sciences; Janssen medical Affairs; Pfizer
Consulting or Advisory Role - Astellas Pharma; Gilead Sciences; Janssen Oncology; Merck; Pfizer
Research Funding - AstraZeneca; Ipsen; MSD Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Roche; Bristol-Myers Squibb/Roche; Pfizer
 
Sylvie Rottey
Consulting or Advisory Role - BMS GmbH & Co. KG (Inst); ipsen (Inst); Janssen (Inst); MSD (Inst); Pfizer (Inst)
Speakers' Bureau - BMS GmbH & Co. KG (Inst); ipsen (Inst); Roche (Inst)
Research Funding - BMS GmbH & Co. KG (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - Merck (Inst); MSD (Inst)
 
Damien Pouessel
Honoraria - AAA/Endocyte/Novartis; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD Oncology; Pfizer/Astellas
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb/Medarex; Eisai; Merck; MSD Oncology; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Pfizer
 
Syed Hussain
Honoraria - Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Merck; Pfizer; Roche
Research Funding - Boehringer Ingelheim; Genentech/Roche (Inst); Janssen-Cilag
Travel, Accommodations, Expenses - Bayer; Boehringer Ingelheim; Janssen-Cilag; MSD Oncology; Pfizer; Pierre Fabre; Roche
 
Elizabeth Steinberg
Employment - Genentech/Roche
Research Funding - Genentech/Roche (Inst)
 
Richard Price
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Research Funding - Genentech/Roche (Inst)
 
Yohann Loriot
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Gilead Sciences; Janssen; Loxo/Lilly; Merck KGaA; MSD Oncology; MSD Oncology (Inst); Pfizer (Inst); Pfizer/EMD Serono; Roche; Roche (Inst); Seagen
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BMS (Inst); Exelixis (Inst); Gilead Sciences (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck KGaA (Inst); MSD Oncology (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Tyra Biosciences (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Janssen Oncology; MSD Oncology; Roche; Seagen
 
Joaquim Bellmunt
Stock and Other Ownership Interests - Rainier Therapeutics
Honoraria - UpToDate
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; EMD Serono/Merck; Merck; Novartis; Pfizer; Pierre Fabre
Research Funding - Pfizer/EMD Serono (Inst); Pfizer/Gilead
Patents, Royalties, Other Intellectual Property - UpToDate Bladder Cancer
Travel, Accommodations, Expenses - Genentech/Roche; Ipsen